_id

690f3a9eccc777a4e85d1963

Ticker

CABA

Name

Cabaletta Bio Inc

Exchange

NASDAQ

Address

2929 Arch Street, Philadelphia, PA, United States, 19104

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.cabalettabio.com

Description

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with autoimmune diseases. Its lead product candidate is resecabtagene autoleucel, a 4-1BB co-stimulatory domain-containing fully human CD19-CAR T, which is in Phase 1/2 clinical trials for the treatment of dermatomyositis, anti-synthetase syndrome, immune-mediated necrotizing myopathy, juvenile myositis, lupus nephritis, non-renal systemic lupus erythematosus, relapsing and progressive multiple sclerosis, mucocutaneous and mucosal pemphigus vulgaris (PV), systemic sclerosis, and generalized myasthenia gravis. The company also develops DSG3-CAART, a CAAR T cell therapy that is in Phase 1 clinical trial for the treatment of mucosal PV; and MuSK-CAART, an investigational cell therapy in Phase 1 trial for treating patients with anti-muscle-specific kinase (MuSK) antibody positive myasthenia gravis. It has collaborations with the University of Pennsylvania and the Children's Hospital of Philadelphia; Nanjing IASO Biotherapeutics Co., Ltd; Oxford Biomedica; Autolus Holdings (UK) Limited; and WuXi Advanced Therapies, Inc. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.

Last Close

2.36

Volume

2604481

Current Price

2.36

Change

0

Last Updated

2025-11-29T11:05:59.108Z

Image

-

Ipo Date

2019-10-25T00:00:00.000Z

Market Cap

247401552

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9940000000000001

Sentiment Sources

3

Rating

4.5

Target Price

14.125

Strong Buy

8

Buy

2

Hold

2

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

345000

Gross Profit

-345000

Operating Expenses

46243000

Operating Income

-46588000

Interest Expense

584000

Pretax Income

-44866000

Net Income

-44866000

Eps

-0.43873191788099425

Dividends Per Share

-

Shares Outstanding

96265204

Income Tax Expense

-

EBITDA

-43937000

Operating Margin

-

Total Other Income Expense Net

1722000

Cash

60206000

Short Term Investments

99725000

Receivables

-

Inventories

-

Total Current Assets

164561000

Property Plant Equipment

21591000

Total Assets

189759000

Payables

8267000

Short Term Debt

21222000

Long Term Debt

-

Total Liabilities

50293000

Equity

139466000

Depreciation

345000

Change In Working Capital

215000

Cash From Operations

-34509000

Capital Expenditures

78000

Cash From Investing

-50080000

Cash From Financing

-806000

Net Change In Cash

-85406000

PE

-

PB

1.730460853828173

ROE

-32.169847848221075

ROA

-23.64367434482686

FCF

-34587000

Fcf Percent

-

Piotroski FScore

1

Health Score

43

Deep Value Investing Score

3.5

Defensive Investing Score

7

Dividend Investing Score

1.5

Economic Moat Investing Score

3.8

Garp Investing Score

2

Growth Investing Score

0.5

Momentum Investing Score

3

Net Net Investing Score

2.5

Quality Investing Score

2.5

Value Investing Score

4.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

345000

Quarters > 0 > income Statement > gross Profit

-345000

Quarters > 0 > income Statement > operating Expenses

46243000

Quarters > 0 > income Statement > operating Income

-46588000

Quarters > 0 > income Statement > interest Expense

584000

Quarters > 0 > income Statement > pretax Income

-44866000

Quarters > 0 > income Statement > net Income

-44866000

Quarters > 0 > income Statement > eps

-0.43873191788099425

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

102262904

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-43937000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

1722000

Quarters > 0 > balance Sheet > cash

60206000

Quarters > 0 > balance Sheet > short Term Investments

99725000

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

164561000

Quarters > 0 > balance Sheet > property Plant Equipment

21591000

Quarters > 0 > balance Sheet > total Assets

189759000

Quarters > 0 > balance Sheet > payables

8267000

Quarters > 0 > balance Sheet > short Term Debt

21222000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

50293000

Quarters > 0 > balance Sheet > equity

139466000

Quarters > 0 > cash Flow > net Income

-44866000

Quarters > 0 > cash Flow > depreciation

345000

Quarters > 0 > cash Flow > change In Working Capital

215000

Quarters > 0 > cash Flow > cash From Operations

-34509000

Quarters > 0 > cash Flow > capital Expenditures

78000

Quarters > 0 > cash Flow > cash From Investing

-50080000

Quarters > 0 > cash Flow > cash From Financing

-806000

Quarters > 0 > cash Flow > net Change In Cash

-85406000

Quarters > 0 > ratios > PE

-0.43873191788099425

Quarters > 0 > ratios > PB

1.730460853828173

Quarters > 0 > ratios > ROE

-32.169847848221075

Quarters > 0 > ratios > ROA

-23.64367434482686

Quarters > 0 > ratios > FCF

-34587000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

43

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

468000

Quarters > 1 > income Statement > gross Profit

-468000

Quarters > 1 > income Statement > operating Expenses

45438000

Quarters > 1 > income Statement > operating Income

-45906000

Quarters > 1 > income Statement > interest Expense

571000

Quarters > 1 > income Statement > pretax Income

-45128000

Quarters > 1 > income Statement > net Income

-45128000

Quarters > 1 > income Statement > eps

-0.7293227199057168

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

61876586

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-44089000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

778000

Quarters > 1 > balance Sheet > cash

145612000

Quarters > 1 > balance Sheet > short Term Investments

49070000

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

198407000

Quarters > 1 > balance Sheet > property Plant Equipment

23591000

Quarters > 1 > balance Sheet > total Assets

224500000

Quarters > 1 > balance Sheet > payables

7193000

Quarters > 1 > balance Sheet > short Term Debt

20414000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

46019000

Quarters > 1 > balance Sheet > equity

178481000

Quarters > 1 > cash Flow > net Income

-45128000

Quarters > 1 > cash Flow > depreciation

468000

Quarters > 1 > cash Flow > change In Working Capital

4065000

Quarters > 1 > cash Flow > cash From Operations

-30426000

Quarters > 1 > cash Flow > capital Expenditures

161000

Quarters > 1 > cash Flow > cash From Investing

-49196000

Quarters > 1 > cash Flow > cash From Financing

93373000

Quarters > 1 > cash Flow > net Change In Cash

13782000

Quarters > 1 > ratios > PE

-0.7293227199057168

Quarters > 1 > ratios > PB

0.818175284540091

Quarters > 1 > ratios > ROE

-25.28448406272937

Quarters > 1 > ratios > ROA

-20.101559020044544

Quarters > 1 > ratios > FCF

-30587000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

42

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

485000

Quarters > 2 > income Statement > gross Profit

-485000

Quarters > 2 > income Statement > operating Expenses

36651000

Quarters > 2 > income Statement > operating Income

-37136000

Quarters > 2 > income Statement > interest Expense

294000

Quarters > 2 > income Statement > pretax Income

-35943000

Quarters > 2 > income Statement > net Income

-35943000

Quarters > 2 > income Statement > eps

-0.7265468658405935

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

49471000

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-35164000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

1193000

Quarters > 2 > balance Sheet > cash

131830000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

134596000

Quarters > 2 > balance Sheet > property Plant Equipment

28176000

Quarters > 2 > balance Sheet > total Assets

165141000

Quarters > 2 > balance Sheet > payables

6492000

Quarters > 2 > balance Sheet > short Term Debt

19194000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

43588000

Quarters > 2 > balance Sheet > equity

121553000

Quarters > 2 > cash Flow > net Income

-35943000

Quarters > 2 > cash Flow > depreciation

485000

Quarters > 2 > cash Flow > change In Working Capital

-3047000

Quarters > 2 > cash Flow > cash From Operations

-30802000

Quarters > 2 > cash Flow > capital Expenditures

785000

Quarters > 2 > cash Flow > cash From Investing

-785000

Quarters > 2 > cash Flow > cash From Financing

-552000

Quarters > 2 > cash Flow > net Change In Cash

-32132000

Quarters > 2 > ratios > PE

-0.7265468658405935

Quarters > 2 > ratios > PB

0.9604992061076238

Quarters > 2 > ratios > ROE

-29.569817281350524

Quarters > 2 > ratios > ROA

-21.765037150071755

Quarters > 2 > ratios > FCF

-31587000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

42

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

1638000

Quarters > 3 > income Statement > cost Of Revenue

468000

Quarters > 3 > income Statement > gross Profit

-468000

Quarters > 3 > income Statement > operating Expenses

33317000

Quarters > 3 > income Statement > operating Income

-33785000

Quarters > 3 > income Statement > interest Expense

748000

Quarters > 3 > income Statement > pretax Income

-32586000

Quarters > 3 > income Statement > net Income

-32586000

Quarters > 3 > income Statement > eps

-0.6491493685007371

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

50198000

Quarters > 3 > income Statement > income Tax Expense

-350000

Quarters > 3 > income Statement > EBITDA

-31370000

Quarters > 3 > income Statement > operating Margin

-2062.5763125763124

Quarters > 3 > income Statement > total Other Income Expense Net

1199000

Quarters > 3 > balance Sheet > cash

163962000

Quarters > 3 > balance Sheet > short Term Investments

0

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

166675000

Quarters > 3 > balance Sheet > property Plant Equipment

16078000

Quarters > 3 > balance Sheet > total Assets

185046000

Quarters > 3 > balance Sheet > payables

4923000

Quarters > 3 > balance Sheet > short Term Debt

9975000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

32711000

Quarters > 3 > balance Sheet > equity

152335000

Quarters > 3 > cash Flow > net Income

-32586000

Quarters > 3 > cash Flow > depreciation

468000

Quarters > 3 > cash Flow > change In Working Capital

2874000

Quarters > 3 > cash Flow > cash From Operations

-23122000

Quarters > 3 > cash Flow > capital Expenditures

376000

Quarters > 3 > cash Flow > cash From Investing

12124000

Quarters > 3 > cash Flow > cash From Financing

4372000

Quarters > 3 > cash Flow > net Change In Cash

-6646000

Quarters > 3 > ratios > PE

-0.6491493685007371

Quarters > 3 > ratios > PB

0.7776760429316966

Quarters > 3 > ratios > ROE

-21.391013227426395

Quarters > 3 > ratios > ROA

-17.609675432054733

Quarters > 3 > ratios > FCF

-23498000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-14.345543345543346

Quarters > 3 > health Score

34

Valuation > metrics > PE

-0.43873191788099425

Valuation > metrics > PB

1.730460853828173

Valuation > final Score

80

Valuation > verdict

Fair

Profitability > metrics > ROE

-32.169847848221075

Profitability > metrics > ROA

-27.26405405898117

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.3606111883900019

Risk > metrics > Interest Coverage

-79.77397260273973

Risk > final Score

-259

Risk > verdict

High

Liquidity > metrics > Current Ratio

5.58041981755909

Liquidity > metrics > Quick Ratio

5.58041981755909

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

70

Prev Valuations > 1

70

Prev Valuations > 2

70

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

0

Prev Risks > 0

-262

Prev Risks > 1

-445

Prev Risks > 2

-121

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-14T00:18:40.718Z